Investigator-initiated study Prof. Nadir Arber, Tel Aviv Sourasky Medical Center
In photo, Professor Nadir Arber the Israeli inventor shows the drug against COVID-19 (Photo from Israel Embassy Manila)
The Israel Embassy Manila invited some media to the briefing and presentation of Prof. Nadir Arber and Dr. Shiran Shapira of Ichilov Hospital, which was entrusted with developing this unique treatment.
The EXO-CD24 is an innovative compound based on enriched CD24 exosomes and is inhaled directly into the lungs to eradicate the cytokine storm that results from the COVID-19 virus. The briefing will be on the record.
Prof. Nadir Arber is an expert in internal medicine and gastroenterology, and is the Director of the Integrated Cancer Prevention Center. He is one of the hospital’s most prominent doctors and researchers and was entrusted with developing the treatment.
Dr. Shiran Shapira is the Head of the Laboratory for Molecular Biology at the Center for Cancer Diagnosis and Prevention at Ichilov Hospital. Dr. Shiran Shapira directs Prof. Arber’s lab and has been leading research into the CD24 protein for over two decades.
Prof. Nadir Arber and Dr. Shiran Shapira of Ichilov Hospital presented a briefing on the topic of the new Israeli treatment for coronavirus. EXO-CD24 is an innovative compound based on enriched CD24 exosomes, and is inhaled directly into the lungs to eradicate the cytokine storm that results from the COVID-19 virus.
Prof. Nadir Arber is an expert in internal medicine and gastroenterology, and is the Director of the Integrated Cancer Prevention Center. He is one of the hospital’s most prominent doctors and researchers and was entrusted with developing the treatment.
Dr. Shiran Shapira is the Head of the Laboratory for Molecular Biology at the Center for Cancer Diagnosis and Prevention at Ichilov Hospital. Dr. Shiran Shapira directs Prof. Arber’s lab and has been leading research into the CD24 protein for over two decades.
The Zoom briefing was held on 17 February 2021 at 10PM PST.
